Heidelberg Pharma AG (ETR:HPHA)
2.780
-0.060 (-2.11%)
Apr 29, 2026, 5:35 PM CET
Heidelberg Pharma AG Employees
Heidelberg Pharma AG had 105 employees as of November 30, 2024. The number of employees increased by 10 or 10.53% compared to the previous year.
Employees
105
Change (1Y)
10
Growth (1Y)
10.53%
Revenue / Employee
€12,784
Profits / Employee
€370,889
Market Cap
130.06M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Merck KGaA | 59,077 |
| Siemens Healthineers AG | 73,800 |
| Bayer Aktiengesellschaft | 87,280 |
| Fresenius SE & Co. KGaA | 178,583 |
| M1 Kliniken AG | 199 |
| Stratec SE | 1,420 |
| MEDICLIN Aktiengesellschaft | 6,974 |
| LIMES Schlosskliniken AG | 237 |
Heidelberg Pharma AG News
- 20 days ago - EQS-Adhoc: Heidelberg Pharma AG: Heidelberg Pharma Determines Recommended Dose for Phase II Trial with ADC Candidate HDP-101 - Wallstreet:Online
- 4 weeks ago - Full Year 2025 Heidelberg Pharma AG Earnings Call Transcript - GuruFocus
- 7 weeks ago - EQS-AFR: Heidelberg Pharma AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act] - Wallstreet:Online
- 7 weeks ago - EQS-DD: Heidelberg Pharma AG: Dr. Birgit Kudlek, sell - Wallstreet:Online
- 7 weeks ago - EQS-Adhoc: Heidelberg Pharma and HealthCare Royalty Announce Amendment to Existing Royalty Agreement and the Participation of Soleus Capital - Wallstreet:Online
- 5 months ago - EQS-News: Heidelberg Pharma Announces Changes to the Executive Management Board – Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer - Wallstreet:Online
- 5 months ago - EQS-Adhoc: Heidelberg Pharma Announces Changes to the Executive Management Board - Dr Dongzhou Jeffery Liu Appointed as Chairman of the Executive Board and Chief Executive Officer - Wallstreet:Online
- 6 months ago - EQS-News: Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma - Wallstreet:Online